Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| KESTRA MEDICAL TECHNOLOGIES, LTD.KMTS · Entity 4686 | Director · See Remarks | August 17, 2026 | August 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
KESTRA MEDICAL TECHNOLOGIES, LTD.
Report date August 17, 2026 · Filed August 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 460,215 |
Reported balance
After 2026-08-17 transaction · row 1
1 source rowRow 1 · 2026-08-17 · Sale · Disposed 15,000 · Balance 460,215 F1: The reported transaction occurred pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2025. F2: The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $26.9200 to $27.7700. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported transaction occurred pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2025.
F2: The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $26.9200 to $27.7700. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 17, 2026 Filed Aug 18, 2026 23:01 UTC | KESTRA MEDICAL TECHNOLOGIES, LTD. KMTS · Entity 4686 | SaleCommon Shares | 15,000 | $27.48 | $412,180.50 |
DisclosureSEC source: 0001193125-26-355847 · ownership.xml · nonDerivative · entry 1 Webster Brian Daniel · CIK 0001877188 · Director · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 460,215 F1 · kind: The reported transaction occurred pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2025. F2 · price: The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $26.9200 to $27.7700. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range. Read SEC document |
| August 04, 2026 Filed Aug 6, 2026 22:59 UTC | KESTRA MEDICAL TECHNOLOGIES, LTD. KMTS · Entity 4686 | SaleCommon Shares | 442 | $25.98 | $11,484.71 |
DisclosureSEC source: 0001193125-26-338657 · ownership.xml · nonDerivative · entry 3 Webster Brian Daniel · CIK 0001877188 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 475,215 F1 · kind: The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the reporting person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units. F4 · price: The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $25.9500 to $26.0300. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range. Read SEC document |
| August 04, 2026 Filed Aug 6, 2026 22:59 UTC | KESTRA MEDICAL TECHNOLOGIES, LTD. KMTS · Entity 4686 | SaleCommon Shares | 2,833 | $25.16 | $71,288.20 |
DisclosureSEC source: 0001193125-26-338657 · ownership.xml · nonDerivative · entry 2 Webster Brian Daniel · CIK 0001877188 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 475,657 F1 · kind: The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the reporting person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units. F3 · price: The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $24.9500 to $25.9300. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range. Read SEC document |
| August 04, 2026 Filed Aug 6, 2026 22:59 UTC | KESTRA MEDICAL TECHNOLOGIES, LTD. KMTS · Entity 4686 | SaleCommon Shares | 48,625 | $24.47 | $1,189,814.85 |
DisclosureSEC source: 0001193125-26-338657 · ownership.xml · nonDerivative · entry 1 Webster Brian Daniel · CIK 0001877188 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 478,490 F1 · kind: The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the reporting person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units. F2 · price: The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $23.9000 to $24.8850. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range. Read SEC document |
| August 03, 2026 Filed Aug 3, 2026 23:26 UTC | KESTRA MEDICAL TECHNOLOGIES, LTD. KMTS · Entity 4686 | SaleCommon Shares | 13,017 | $23.92 | $311,423.91 |
DisclosureSEC source: 0001193125-26-331055 · ownership.xml · nonDerivative · entry 3 Webster Brian Daniel · CIK 0001877188 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 527,115 F1 · kind: The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the reporting person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units. F4 · price: The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $23.6400 to $24.1100. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range. Read SEC document |
| July 31, 2026 Filed Aug 3, 2026 23:26 UTC | KESTRA MEDICAL TECHNOLOGIES, LTD. KMTS · Entity 4686 | SaleCommon Shares | 8,948 | $22.60 | $202,259.70 |
DisclosureSEC source: 0001193125-26-331055 · ownership.xml · nonDerivative · entry 2 Webster Brian Daniel · CIK 0001877188 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 540,132 F1 · kind: The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the reporting person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units. F3 · price: The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $22.0577 to $22.9200. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range. Read SEC document |
| July 30, 2026 Filed Aug 3, 2026 23:26 UTC | KESTRA MEDICAL TECHNOLOGIES, LTD. KMTS · Entity 4686 | SaleCommon Shares | 7,857 | $22.72 | $178,530.68 |
DisclosureSEC source: 0001193125-26-331055 · ownership.xml · nonDerivative · entry 1 Webster Brian Daniel · CIK 0001877188 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 549,080 F1 · kind: The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the reporting person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units. F2 · price: The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $22.2524 to $23.1700. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range. Read SEC document |
| July 15, 2026 Filed Jul 17, 2026 21:48 UTC | KESTRA MEDICAL TECHNOLOGIES, LTD. KMTS · Entity 4686 | SaleCommon Shares | 3,000 | $24.00 | $71,994.90 |
DisclosureSEC source: 0001193125-26-308041 · ownership.xml · nonDerivative · entry 4 Webster Brian Daniel · CIK 0001877188 · Director · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 556,937 F2 · kind: The reported transaction occurred pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2025. F5 · price: The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $23.49 to $24.10. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range. Read SEC document |
| July 15, 2026 Filed Jul 17, 2026 21:48 UTC | KESTRA MEDICAL TECHNOLOGIES, LTD. KMTS · Entity 4686 | SaleCommon Shares | 784 | $22.63 | $17,744.51 |
DisclosureSEC source: 0001193125-26-308041 · ownership.xml · nonDerivative · entry 3 Webster Brian Daniel · CIK 0001877188 · Director · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 559,937 F2 · kind: The reported transaction occurred pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2025. F4 · price: The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $22.45 to $23.00. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range. Read SEC document |
| July 15, 2026 Filed Jul 17, 2026 21:48 UTC | KESTRA MEDICAL TECHNOLOGIES, LTD. KMTS · Entity 4686 | SaleCommon Shares | 11,216 | $22.01 | $246,869.77 |
DisclosureSEC source: 0001193125-26-308041 · ownership.xml · nonDerivative · entry 2 Webster Brian Daniel · CIK 0001877188 · Director · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 560,721 F2 · kind: The reported transaction occurred pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2025. F3 · price: The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $21.45 to $22.44. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range. Read SEC document |
| July 15, 2026 Filed Jul 17, 2026 21:48 UTC | KESTRA MEDICAL TECHNOLOGIES, LTD. KMTS · Entity 4686 | GrantCommon Shares | 176,470 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-308041 · ownership.xml · nonDerivative · entry 1 Webster Brian Daniel · CIK 0001877188 · Director · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 571,937 F1 · shares: Represents common shares earned with respect to an award of performance-based RSUs ("PSUs") granted on July 17, 2025, as determined based on the Issuer's achievement of specified performance goals. 100% of the PSUs vested on July 15, 2026. Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 20:36 UTC | KESTRA MEDICAL TECHNOLOGIES, LTD. KMTS · Entity 4686 | SaleCommon Shares | 15,000 | $20.81 | $312,142.50 |
DisclosureSEC source: 0001193125-26-274257 · ownership.xml · nonDerivative · entry 1 Webster Brian Daniel · CIK 0001877188 · Director · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 395,467 F1 · kind: The reported transaction occurred pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2025. F2 · price: The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $20.5400 to $21.3900. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range. Read SEC document |
| June 03, 2026 Filed Jun 4, 2026 22:35 UTC | KESTRA MEDICAL TECHNOLOGIES, LTD. KMTS · Entity 4686 | GrantCommon Shares | 75,681 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-257907 · ownership.xml · nonDerivative · entry 1 Webster Brian Daniel · CIK 0001877188 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 410,467 F1 · shares: Represents restricted stock units ("RSU") that entitle the Reporting Person to receive, at settlement, one common share of Kestra Medical Technologies, Ltd. Subject to the Reporting Person's continued service, the RSUs will vest over three years, with 1/3 vesting on each anniversary of June 3, 2026. Read SEC document |
| May 15, 2026 Filed May 18, 2026 21:40 UTC | KESTRA MEDICAL TECHNOLOGIES, LTD. KMTS · Entity 4686 | SaleCommon Shares | 6,845 | $21.46 | $146,917.66 |
DisclosureSEC source: 0001193125-26-229188 · ownership.xml · nonDerivative · entry 2 Webster Brian Daniel · CIK 0001877188 · Director · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 334,786 F1 · kind: The reported transaction occurred pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2025. F3 · price: The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $21.2433 to $21.6300. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range. Read SEC document |
| May 15, 2026 Filed May 18, 2026 21:40 UTC | KESTRA MEDICAL TECHNOLOGIES, LTD. KMTS · Entity 4686 | SaleCommon Shares | 8,155 | $20.53 | $167,411.55 |
DisclosureSEC source: 0001193125-26-229188 · ownership.xml · nonDerivative · entry 1 Webster Brian Daniel · CIK 0001877188 · Director · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 341,631 F1 · kind: The reported transaction occurred pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2025. F2 · price: The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $20.2200 to $20.2115. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range. Read SEC document |
| April 15, 2026 Filed Apr 16, 2026 21:03 UTC | KESTRA MEDICAL TECHNOLOGIES, LTD. KMTS · Entity 4686 | SaleCommon Shares | 15,000 | $20.04 | $300,670.50 |
DisclosureSEC source: 0001193125-26-159276 · ownership.xml · nonDerivative · entry 1 Webster Brian Daniel · CIK 0001877188 · Director · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 349,786 F1 · kind: The reported transaction occurred pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2025. F2 · price: The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $20.0000 to $20.2200. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range. Read SEC document |
| March 17, 2026 Filed Mar 19, 2026 20:10 UTC | KESTRA MEDICAL TECHNOLOGIES, LTD. KMTS · Entity 4686 | SaleCommon Shares | 15,000 | $20.27 | $304,123.50 |
DisclosureSEC source: 0001193125-26-115983 · ownership.xml · nonDerivative · entry 1 Webster Brian Daniel · CIK 0001877188 · Director · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 364,786 F1 · kind: The reported transaction occurred pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2025. F2 · price: The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $20.0000 to $20.7709. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 21:35 UTC | KESTRA MEDICAL TECHNOLOGIES, LTD. KMTS · Entity 4686 | SaleCommon Shares | 93 | $27.18 | $2,527.64 |
DisclosureSEC source: 0001193125-26-059532 · ownership.xml · nonDerivative · entry 3 Webster Brian Daniel · CIK 0001877188 · Director · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 379,786 F1 · kind: The reported transaction occurred pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2025. F4 · price: The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $27.0771 to $27.1800. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 21:35 UTC | KESTRA MEDICAL TECHNOLOGIES, LTD. KMTS · Entity 4686 | SaleCommon Shares | 3,272 | $26.29 | $86,036.26 |
DisclosureSEC source: 0001193125-26-059532 · ownership.xml · nonDerivative · entry 2 Webster Brian Daniel · CIK 0001877188 · Director · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 379,879 F1 · kind: The reported transaction occurred pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2025. F3 · price: The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $26.0200 to $26.9998. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 21:35 UTC | KESTRA MEDICAL TECHNOLOGIES, LTD. KMTS · Entity 4686 | SaleCommon Shares | 11,635 | $25.39 | $295,455.70 |
DisclosureSEC source: 0001193125-26-059532 · ownership.xml · nonDerivative · entry 1 Webster Brian Daniel · CIK 0001877188 · Director · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 383,151 F1 · kind: The reported transaction occurred pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2025. F2 · price: The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $25.0150 to $26.0100. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range. Read SEC document |
| January 15, 2026 Filed Jan 20, 2026 11:00 UTC | KESTRA MEDICAL TECHNOLOGIES, LTD. KMTS · Entity 4686 | SaleCommon Shares | 15,000 | $22.80 | $342,024.00 |
DisclosureSEC source: 0001193125-26-015862 · ownership.xml · nonDerivative · entry 1 Webster Brian Daniel · CIK 0001877188 · Director · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 394,786 F1 · kind: The reported transaction occurred pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2025. F2 · price: The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $22.2800 to $23.1340. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range. Read SEC document |
| December 29, 2025 Filed Dec 31, 2025 21:14 UTC | KESTRA MEDICAL TECHNOLOGIES, LTD. KMTS · Entity 4686 | SaleCommon Shares | 15,000 | $26.59 | $398,847.00 |
DisclosureSEC source: 0001193125-25-338322 · ownership.xml · nonDerivative · entry 1 Webster Brian Daniel · CIK 0001877188 · Director · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 409,786 F1 · kind: The reported transaction occurred pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2025. F2 · price: The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $26.390 to $26.9504. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range. F3 · balance_after: Includes 27,209 Common Shares received from West Affum Holdings, L.P. in a pro rata distribution exempt pursuant to Rule 16a-9. Read SEC document |
| July 17, 2025 Filed Jul 21, 2025 21:20 UTC | KESTRA MEDICAL TECHNOLOGIES, LTD. KMTS · Entity 4686 | GrantCommon Shares | 88,235 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-097326 · ownership.xml · nonDerivative · entry 1 Webster Brian Daniel · CIK 0001877188 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 397,577 F1 · shares: Represents restricted stock units ("RSU") that entitle the Reporting Person to receive, at settlement, one common share of Kestra Medical Technologies, Ltd. Subject to the Reporting Person's continued service, the RSUs will vest 29,333 on July 17, 2026, 29,333 on July 17, 2027 and 29,334 on July 17, 2028. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.